A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

Status:
Completed

Trial end date:
2005-01-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety of tolterodine in impacting the primary symptom or complaint of patients with OAB.

Phase 4

Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Tolterodine Tartrate